Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AquADEKs-2 in Cystic Fibrosis
NCT01859390Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Jun 2013
- Primary completion
- Apr 2015
- Modality
- Nutraceutical
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AquADEKs in cystic fibrosis (CF), sponsored by University of Colorado Denver. Started Jun 2013; status: completed.
02
Drugs
AquADEKs
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01859390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01859390.